Cellvoyant Technologies Limited
13594965
Healthy
- Current liabilities exceed current assets (-10)
Details
Compliance
Accounts
Confirmation statement
Industry
Officers
director · Since 31/08/2021
SCIENTIST
BRITISH,COSTA RICAN · ENGLAND · Age 53
director · Since 26/01/2024
INVESTOR
BRITISH · UNITED KINGDOM · Age 31
Also on 2 other boards
Persons with Significant Control
Dr Rafael Edgardo Carazo Salas
British,Costa Rican · England · Age 53
C/O Origin Workspace, 40 Berkeley Square, Bristol, BS8 1HP
Notified 31/08/2021
CompanyRankvs 1839+ SIC 72190 peers67
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/08/2025
Net Worth
£281
Balance sheet strength
Cash
£207k
Cash in the bank
Net Current Assets
£2.1M
Working capital
Current Assets
£2.5M
Current Liabilities
£350k
Fixed Assets
£1.3M
Debtors
£751k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2025 | 7.06 | — |
| 2024 | 59.48 | +£5.9M |
| 2023 | 1.88 | -£1.1M |
| 2022 | 27.75 | — |
Derived from filed accounts. Not audited figures.